Patients often prefer authorized generics over traditional ones because they're identical to brand-name drugs-same ingredients, same manufacturer. But price still drives most choices after the initial 180-day window. Here's what the data really shows.
Compulsory licensing lets governments override patents to make life-saving drugs affordable during emergencies. Used in HIV, COVID-19, and cancer treatments, it balances innovation with public health needs.
Despite generics making up 90% of prescriptions, most doctors receive little training on bioequivalence. This article explores why physicians still doubt generic drugs and what medical education must change to close the knowledge-behavior gap.
Authorized generics are exact copies of brand-name drugs, while traditional generics may have different inactive ingredients. Learn the key differences, when each matters, and how to ensure you get the right one.
Clinical outcomes data shows generic drugs are just as effective and safe as brand-name medications for most conditions. Providers can confidently prescribe generics to improve adherence and reduce costs without compromising care.